Sinai Intellectual Property Co Cedars serves as Executive at Prometheus Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Sinai Intellectual Property Co Cedars has executed 2 insider transactions totaling $99.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 8, 2023 involved selling 865,000 shares valued at $99.1M.
Sinai Intellectual Property Co Cedars currently holds 4,001,132 shares of Prometheus Biosciences, Inc. (RXDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sinai Intellectual Property Co Cedars has been a net seller of RXDX stock. They have purchased $0 and sold $99.1M worth of shares.
Sinai Intellectual Property Co Cedars's most recent insider trade was on Mar 8, 2023, when they sold 865,000 shares at $114.59 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |